Publicaciones en las que colabora con Marta Aymerich (11)

2019

  1. Expression of the transcribed ultraconserved region 70 and the related long non-coding RNA AC092652.2-202 has prognostic value in Chronic Lymphocytic Leukaemia

    British Journal of Haematology

2018

  1. Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia

    Leukemia, Vol. 32, Núm. 3, pp. 645-653

2017

  1. Improved classification of leukemic B-cell lymphoproliferative disorders using a transcriptional and genetic classifier

    Haematologica

2016

  1. Clinical impact of clonal and subclonal TP53, SF3B1, BIRC3, NOTCH1, and ATM mutations in chronic lymphocytic leukemia

    Blood, Vol. 127, Núm. 17, pp. 2122-2130

2015

  1. A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact

    Leukemia, Vol. 29, Núm. 3, pp. 598-605

  2. Detection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemia

    Genes Chromosomes and Cancer, Vol. 54, Núm. 11, pp. 668-680

  3. Non-coding recurrent mutations in chronic lymphocytic leukaemia

    Nature, Vol. 526, Núm. 7574, pp. 519-524

2014

  1. Dual PI3K/mTOR inhibition is required to effectively impair microenvironment survival signals in mantle cell lymphoma

    Oncotarget, Vol. 5, Núm. 16, pp. 6788-6800

  2. Genomic complexity and IGHV mutational status are key predictors of outcome of chronic lymphocytic leukemia patients with TP53 disruption

    Haematologica

2013

  1. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Núm. 45, pp. 18250-18255

2008

  1. Gene expression profile and genomic changes in disease progression of early-stage chronic lymphocytic leukemia

    Haematologica, Vol. 93, Núm. 1, pp. 132-136